These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 12569609)

  • 21. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
    Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
    Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
    Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
    Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
    Kawasaki H; Altieri DC; Lu CD; Toyoda M; Tenjo T; Tanigawa N
    Cancer Res; 1998 Nov; 58(22):5071-4. PubMed ID: 9823313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
    Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
    Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S
    Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
    Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
    Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
    Kristt DA; Yarden Y
    Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.
    Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB
    Anticancer Res; 2003; 23(4):3327-31. PubMed ID: 12926071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
    Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.
    Tanaka K; Iwamoto S; Gon G; Nohara T; Iwamoto M; Tanigawa N
    Clin Cancer Res; 2000 Jan; 6(1):127-34. PubMed ID: 10656440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.